NCT00196612View on ClinicalTrials.gov

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2001

Study Completion Date

September 30, 2004

Conditions
HIV Infections
Interventions
DRUG

emtricitabine, FTC (drug)

DRUG

didanosine, ddI (drug)

DRUG

efavirenz (drug)

Sponsors
All Listed Sponsors
collaborator

Triangle Pharmaceuticals

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Dupont Applied Biosciences

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV